These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 28609797)
1. Response to: "More on the Limitations of the aPTT for Monitoring Argatroban Therapy". Van Cott EM; Roberts AJ; Dager WE Semin Thromb Hemost; 2017 Sep; 43(6):644. PubMed ID: 28609797 [No Abstract] [Full Text] [Related]
2. More on the Limitations of the Activated Partial Thromboplastin Time for Monitoring Argatroban Therapy. Guy S; Van Veen J; Kitchen S Semin Thromb Hemost; 2017 Sep; 43(6):642-643. PubMed ID: 28618436 [No Abstract] [Full Text] [Related]
3. Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia. Vo QA; Lin JK; Tong LM Ann Pharmacother; 2015 Feb; 49(2):178-84. PubMed ID: 25515865 [TBL] [Abstract][Full Text] [Related]
4. Argatroban and lepirudin requirements in a 6-year-old patient with heparin-induced thrombocytopenia. John TE; Hallisey RK Pharmacotherapy; 2005 Oct; 25(10):1383-8. PubMed ID: 16185183 [TBL] [Abstract][Full Text] [Related]
5. Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome. Pendleton R; Wheeler MM; Rodgers GM Ann Pharmacother; 2006 May; 40(5):972-6. PubMed ID: 16569813 [TBL] [Abstract][Full Text] [Related]
6. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia. Guzzi LM; McCollum DA; Hursting MJ J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051 [TBL] [Abstract][Full Text] [Related]
7. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction. Levine RL; Hursting MJ; McCollum D Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006 [TBL] [Abstract][Full Text] [Related]
8. Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban. Guy S; Kitchen S; Maclean R; Van Veen JJ Int J Lab Hematol; 2015 Dec; 37(6):834-43. PubMed ID: 26305560 [TBL] [Abstract][Full Text] [Related]
9. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia. Shapiro NL; Durr EA; Krueger CD Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study. Hursting MJ; Verme-Gibboney CN J Cardiovasc Pharmacol; 2008 Dec; 52(6):561-6. PubMed ID: 19057393 [TBL] [Abstract][Full Text] [Related]
11. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial. Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113 [TBL] [Abstract][Full Text] [Related]
12. Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patients. Smythe MA; Koerber JM; Forsyth LL; Priziola JL; Balasubramaniam M; Mattson JC Pharmacotherapy; 2009 Sep; 29(9):1073-81. PubMed ID: 19698012 [TBL] [Abstract][Full Text] [Related]
14. A case series describing the use of argatroban in patients on extracorporeal circulation. Cornell T; Wyrick P; Fleming G; Pasko D; Han Y; Custer J; Haft J; Annich G ASAIO J; 2007; 53(4):460-3. PubMed ID: 17667231 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia. Kiser TH; Jung R; MacLaren R; Fish DN Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293 [TBL] [Abstract][Full Text] [Related]
16. Argatroban anticoagulation in critically ill patients. Beiderlinden M; Treschan TA; Görlinger K; Peters J Ann Pharmacother; 2007 May; 41(5):749-54. PubMed ID: 17440009 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Dang CH; Durkalski VL; Nappi JM Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503 [TBL] [Abstract][Full Text] [Related]
18. Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban. Zayac EA; Pivalizza EG; Levine RL Anesth Analg; 2008 Jan; 106(1):351-2. PubMed ID: 18165611 [No Abstract] [Full Text] [Related]